Immune checkpoint inhibitors for invasive mucinous adenocarcinoma: A case series
Oncology Letters · 29.05.2026 · 32 (1) · 1-7
DOI: 10.3892/ol.2026.15674 ↗Kurz gefasst
Fallbericht in der Zeitschrift Oncology Letters, online erschienen am 29.05.2026. Verfasst von Tatsuya Kato und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory Medicine, Respiratory Center, Toranomon Hospital, Tokyo 105-8470, Japan. Die Arbeit nennt 15 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Respiratory Medicine, Respiratory Center, Toranomon Hospital, Tokyo 105-8470, Japan.
- Department of Diagnostic Pathology, Toranomon Hospital, Tokyo 105-8470, Japan.
- Okinaka Memorial Institute for Medical Research, Tokyo 105-8470, Japan.
Zitieren
APA
Kato, T., Mitsumura, T., Tsuboi, E., Nakahama, H., Takahashi, Y., Nei, Y., Hanada, S., Miyamoto, A., Uruga, H., Fujii, T., & Tamaoka, M. (2026). Immune checkpoint inhibitors for invasive mucinous adenocarcinoma: A case series. Oncology Letters, 32(1), 1-7. https://doi.org/10.3892/ol.2026.15674
Vancouver
Kato T, Mitsumura T, Tsuboi E, Nakahama H, Takahashi Y, Nei Y, et al. Immune checkpoint inhibitors for invasive mucinous adenocarcinoma: A case series. Oncology Letters. 2026;32(1):1-7. doi:10.3892/ol.2026.15674
BibTeX
@article{Kato2026,
author = {Kato, Tatsuya and Mitsumura, Takahiro and Tsuboi, Eiyu and Nakahama, Hiroshi and Takahashi, Yui and Nei, Yuichiro and Hanada, Shigeo and Miyamoto, Atsushi and Uruga, Hironori and Fujii, Takeshi and Tamaoka, Meiyo},
title = {Immune checkpoint inhibitors for invasive mucinous adenocarcinoma: A case series},
journal = {Oncology Letters},
year = {2026},
volume = {32},
number = {1},
pages = {1--7},
doi = {10.3892/ol.2026.15674}
}
EUVIMED